⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DYN News
Dyne Therapeutics, Inc. Common Stock
Dyne Therapeutics Appoints Barry Greene to Board of Directors
globenewswire.com
DYN
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
DYN
Form 8-K
sec.gov
DYN
Dyne Therapeutics Announces Expanded Debt Facility of Up To $400 Million with Hercules Capital, Inc.
globenewswire.com
DYN
HTGC
The Authority Images and Vaults Over 10 million Collectibles in Less Than Six Months After Launch
prnewswire.com
DYN
Form 8-K
sec.gov
DYN
Form 8-K
sec.gov
DYN
Dyne Therapeutics Announces Completion of Enrollment in Registrational Expansion Cohort of ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1 (DM1)
globenewswire.com
DYN
Dyne Therapeutics Announces Submission of Biologics License Application (BLA) to U.S. FDA for Z-Rostudirsen in Exon 51 Duchenne Muscular Dystrophy (DMD)
globenewswire.com
DYN
It’s Time to Set Things Right at Dynacor and Ensure the Viability and Success of the Company
businesswire.com
DYN